Consensus statement on the management of the GH-treated adolescent in the transition to adult care

被引：191

作者：

Clayton, PE

Cuneo, RC

Juul, A

Monson, JP

Shalet, SM

Tauber, M

机构：

[1] Univ Manchester, Endocrine Sci Res Grp, Manchester M13 9PT, Lancs, England

[2] Univ Queensland, Metab Res Unit, Brisbane, Qld, Australia

[3] Princess Alexandra Hosp, Dept Endocrinol & Diabet, Brisbane, Qld 4102, Australia

[4] Rigshosp, Dept Growth & Reprod, Copenhagen, Denmark

[5] St Bartholomews Hosp, London, England

[6] Christie Hosp, Manchester, Lancs, England

[7] Hop Enfants, Toulouse, France

来源：

EUROPEAN JOURNAL OF ENDOCRINOLOGY | 2005年 / 152卷 / 02期

关键词：

D O I：

10.1530/eje.1.01829

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The European Society for Paediatric Endocrinology held a consensus workshop in Manchester, UK in December 2003 to discuss issues relating to the care of GH-treated patients in the transition from paediatric to adult life. Clinicians experienced in the care of paediatric and adult patients on GH treatment, from a wide range of countries, as well as medical representatives from the pharmaceutical manufacturers of GH participated.

引用

收藏

页码：165 / 170

页数：6

相关论文

共 20 条

[1]

Attanasio A, 1998, J CLIN ENDOCR METAB, V83, P379

[2] Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severelv GH-deficient (GHD) patients after childhood GH treatment: A comparison with adult onset GFID patients [J].

Attanasio, AF ;

Howell, S ;

Bates, PC ;

Frewer, P ;

Chipman, J ;

Blum, WF ;

Shalet, SM .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (07) :3368-3372

[3] Longitudinal changes of lumbar bone mineral density (BMD) in patients with GH deficiency after discontinuation of treatment at final height; timing and peak values for lumbar BMD [J].

Baroncelli, GI ;

Bertelloni, S ;

Sodini, F ;

Saggese, G .

CLINICAL ENDOCRINOLOGY, 2004, 60 (02) :175-184

[4]

Christiansen JS, 2001, J CLIN ENDOCR METAB, V86, P1868

[5] The cardiovascular risk of GH-defficient adolescents [J].

Colao, A ;

Di Somma, C ;

Salerno, M ;

Spinelli, L ;

Orio, F ;

Lombardi, G .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08) :3650-3655

[6] The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growth [J].

Drake, WM ;

Carroll, PV ;

Maher, KT ;

Metcalfe, KA ;

Camacho-Hübner, C ;

Shaw, NJ ;

Dunger, DB ;

Cheetham, TD ;

Savage, MO ;

Monson, JP .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (04) :1658-1663

[7] Turner's syndrome in adulthood [J].

Elsheikh, M ;

Dunger, DB ;

Conway, GS ;

Wass, JAH .

ENDOCRINE REVIEWS, 2002, 23 (01) :120-140

[8] The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults:: evidence for growth hormone modulation of extrarenal 11β-hydroxysteroid dehydrogenase activity [J].

Gelding, SV ;

Taylor, NF ;

Wood, PJ ;

Noonan, K ;

Weaver, JU ;

Wood, DF ;

Monson, JP .

CLINICAL ENDOCRINOLOGY, 1998, 48 (02) :153-162

[9] Importance of estrogen on bone health in turner syndrome:: A cross-sectional and longitudinal study using dual-energy X-ray absorptiometry [J].

Högler, W ;

Briody, J ;

Moore, B ;

Garnett, S ;

Lu, PW ;

Cowell, CT .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01) :193-199

[10] An assessment of optimal hydrocortisone replacement therapy [J].

Howlett, TA .

CLINICAL ENDOCRINOLOGY, 1997, 46 (03) :263-268